# Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)

> **NCT01923376** · NA · WITHDRAWN · sponsor: **New York Presbyterian Brooklyn Methodist Hospital**

## Conditions studied

- Hepatic Encephalopathy
- HE
- Cirrhosis
- Altered Mental Status
- AMS

## Interventions

- **DRUG:** Lactulose
- **DRUG:** Polyethylene Glycol 3350

## Key facts

- **NCT ID:** NCT01923376
- **Lead sponsor:** New York Presbyterian Brooklyn Methodist Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-02
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not enough staff to collect data
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923376, "Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01923376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*